Merit Medical Systems Inc (MMSI)

Return on equity (ROE)

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Net income (ttm)	US$ in thousands	94,411	100,183	89,621	84,674	74,516	61,728	58,423	48,041	48,454	43,219	28,243	4,269	-9,843	-29,426	-29,815	-3,898	5,451	18,844	38,861	42,943
Total stockholders’ equity	US$ in thousands	1,202,000	1,229,880	1,203,700	1,171,660	1,144,400	1,088,840	1,073,310	1,056,520	1,039,800	1,013,380	992,434	976,692	958,575	933,837	928,847	939,798	949,944	949,241	950,675	940,111
ROE		7.85%	8.15%	7.45%	7.23%	6.51%	5.67%	5.44%	4.55%	4.66%	4.26%	2.85%	0.44%	-1.03%	-3.15%	-3.21%	-0.41%	0.57%	1.99%	4.09%	4.57%

December 31, 2023 calculation

ROE = Net income (ttm) ÷ Total stockholders’ equity
= $94,411K ÷ $1,202,000K
= 7.85%

The return on equity (ROE) for Merit Medical Systems, Inc. has shown a positive trend throughout the quarters displayed in the table. The ROE increased from 6.51% in Q4 2022 to 7.85% in Q4 2023, indicating an improvement in the company's ability to generate profits from shareholders' equity during this period.

The average ROE over the quarters is approximately 6.74%, suggesting that, on average, the company generated a return of 6.74% on each dollar of shareholders' equity. This demonstrates a decent level of efficiency in utilizing shareholders' funds to generate profits.

Overall, the increasing trend in ROE indicates a positive financial performance for Merit Medical Systems, Inc. It signals that the company is effectively utilizing shareholder funds to generate profits, which may imply strong management and operational efficiency in creating value for shareholders.